Medicover AB announced consolidated and company earnings results for the first quarter ended March 31, 2018. For the quarter, on consolidated basis, the company announced revenue of EUR 161.9 million compared to EUR 141.9 million for the same period a year ago. Operating profit was EUR 8.1 million compared to EUR 6.8 million for the same period a year ago. Profit before income tax was EUR 11.6 million compared to EUR 6.5 million for the same period a year ago. Profit attributable to owners of the parent company was EUR 9.0 million or EUR 0.067 per basic and diluted share compared to EUR 3.9 million or EUR 0.040 per basic and diluted share for the same period a year ago. Net cash flow from operating activities was EUR 6.6 million compared to EUR 8.8 million for the same period a year ago. Payment for acquisition of fixed assets was EUR 10.3 million compared to EUR 4.0 million for the same period a year ago. EBITDA was EUR 15.0 million compared to EUR 13.2 million for the same period a year ago. Adjusted EBITDA was EUR 15.5 million compared to EUR 13.4 million for the same period a year ago. Growth CapEx was EUR 6.8 million out of a total of some EUR 10.9 million for the quarter. For the quarter, on company basis, the company announced revenue of EUR 0.1 million compared to nil for the same period a year ago. Operating loss was EUR 0.5 million compared to EUR 0.1 million for the same period a year ago. Loss before income tax was EUR 0.4 million compared to EUR 0.1 million for the same period a year ago. Loss for the period was EUR 0.4 million compared to EUR 0.1 million a year ago. For the year 2018, the company expects effective tax rate of 29%.